berberine has been researched along with curcumin in 79 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (6.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (11.39) | 29.6817 |
| 2010's | 40 (50.63) | 24.3611 |
| 2020's | 25 (31.65) | 2.80 |
| Authors | Studies |
|---|---|
| Sashidhara, KV; Singh, SP | 1 |
| Atanasov, AG; Kamal, MA; Khan, H; Nabavi, SM; Pervaiz, A; Rengasamy, KRR | 1 |
| Alharthi, S; Moyle, PM; Ziora, ZM | 1 |
| Liu, S; Ren, L; Yang, L; Zhang, H | 1 |
| Hur, GM; Kim, YH; Lee, CJ; Lee, JH; Park, YC; Seok, JH; Seol, IC | 1 |
| Koizumi, K; Matsuo, M; Saiki, I; Sakurai, H | 1 |
| Harikumar, KB; Kuttan, G; Kuttan, R | 1 |
| Efferth, T; Hoheisel, JD; Youns, M | 1 |
| Weng, J; Xia, X | 1 |
| Jiang, W; Kou, J; Sun, L; Yu, B; Yuan, S | 1 |
| Kim, MH; Kim, SH; Yang, WM | 1 |
| Chen, CY; Li, WC; Ting, CT; Tsai, TH | 1 |
| Balakrishna, A; Kumar, MH | 1 |
| Srivastava, P; Tiwari, A | 1 |
| Bharti, AC; Dwivedi, M; Mahata, S; Mehrotra, R; Misra, SP; Misra, V; Pandey, A; Tripathi, SC; Vishnoi, K | 1 |
| Cicero, AF; Colletti, A | 1 |
| Allijn, IE; Beukelman, KJ; de Winther, MP; Quarles van Ufford, LC; Schiffelers, RM; Storm, G; Vaessen, SF | 1 |
| Bao, J; Chen, M; He, C; Jia, X; Li, P; Liang, Y; Su, H; Wan, JB; Wang, K; Wang, X; Zhang, C | 1 |
| Awasthi, A; Bharate, SS; Gopalakrishna Pillai, GK; Jaggi, M; Mishra, G; Mithal, A; Singh, AT; Verma, R; Vishwakarma, RA | 1 |
| Bianchi, S; Giovannini, L | 1 |
| Abrams, SL; Candido, S; Cervello, M; Cocco, L; Gizak, A; Lertpiriyapong, K; Libra, M; Martelli, AM; McCubrey, JA; Montalto, G; Rakus, D; Ratti, S; Steelman, LS | 1 |
| Calabresi, L; Pavanello, C; Ruscica, M; Sirtori, CR | 1 |
| Gao, H; Jiang, Y; Turdu, G | 1 |
| Abrams, SL; Candido, S; Cervello, M; Cocco, L; Gizak, A; Lertpiriyapong, K; Libra, M; Lombardi, P; Martelli, AM; McCubrey, JA; Montalto, G; Murata, RM; Rakus, D; Ratti, S; Rosalen, PL; Steelman, LS | 1 |
| Gao, Z; Li, Q; Tong, X; Wu, X; Zhao, L; Zhao, X | 1 |
| Feng, WW; Kuang, SY; Liu, TS; Ma, ZJ; Pang, JY; Tu, C; Wang, JB; Wang, YH; Xiao, XH; Zang, QC; Zhao, YL | 1 |
| Bianchi, S; Daniele, S; Franzoni, F; Fusi, J; Galetta, F; Giovannini, L; Martini, C; Pellegrini, S | 1 |
| Bianconi, V; Cosentino, T; Mannarino, MR; Pirro, M; Sahebkar, A | 1 |
| Chen, C; Geng, C; Hidru, TH; Li, H; Liu, Y; Tao, M; Zhang, Y; Zhi, L; Zou, L | 1 |
| Bellentani, S; Cicero, AFG; Colletti, A | 1 |
| Chen, D; Cheng, Z; Fan, X; Fang, L; Hou, X; Wang, Z; Zhang, W | 1 |
| Dunbar, GL; Maiti, P; Plemmons, A | 1 |
| Chen, CH; Li, C; Li, M; Lin, L; Yuan, M; Zhang, D | 1 |
| D'Arcy, MS | 1 |
| Kaur, A; Kumar, S; Maurya, VK; Mishra, S; Saxena, SK | 1 |
| Campiglia, P; Carrizzo, A; Ciccarelli, M; Di Pietro, P; Forte, M; Frati, G; Galasso, G; Izzo, C; Rubattu, S; Sciarretta, S; Sommella, E; Vecchione, C; Venturini, E | 1 |
| Banerjee, R; Bhatia, E; Jadhav, K; Sharma, S | 1 |
| Dong, C; Gong, X; Jiao, Y; Liu, Y; Meng, Y; Shuang, S; Zhang, H; Zhang, Y | 1 |
| Bellanti, JA; Boner, AL; Concia, E; Girotto, S; Piazza, M | 1 |
| Chen, Y; Du, Q; Gong, Z; Huang, J; Jiang, Z; Lu, Y; Peng, J; Shen, X; Sun, R; Xu, J; Zhang, J; Zhou, J | 1 |
| Akter, R; Bibi, P; Hassan, SSU; Mubin, S; Najda, A; Rahman, MH; Saeeda, S; Shah, M; Wesołowska, S | 1 |
| Avila-Carrasco, L; Díaz-Avila, DL; García-Mayorga, EA; Garza-Veloz, I; González-Mateo, GT; Martinez-Fierro, ML | 1 |
| Ghasemi, F; Sahebkar, A; Ziasarabi, P | 1 |
| Asoodeh, A; Ghobadi-Oghaz, N; Mohammadi, M | 1 |
| Cao, Y; Chen, X; Gao, Y; Li, X; Li, Y; Luo, L; Tang, G; Tian, Y; Wang, H; Yu, X; Zhou, Z | 1 |
| Akter, A; Alhumaydhi, FA; Baghayeri, M; Eftekhari, A; Emran, TB; Islam, F; Islam, MM; Islam, MR; Karimi, F; Khan Meem, AF; Khusro, A; Mitra, S; Nafady, MH; Simal-Gandara, J | 1 |
| Arulmozhi, S; Diddi, S; Lohidasan, S; Mahadik, KR | 1 |
| Le, TT; Urasaki, Y | 2 |
| Gupta, P; Lather, V; Mukherjee, M; Nagpal, D; Parmar, VS; Sharma, HK | 1 |
| Biernaciak, A; Erdmann, J; Janowski, K; Kuźmiński, O; Michalak, K; Nowacka, A; Ohla, J; Szambelan, M; Wiciński, M; Zabrzyński, J | 1 |
| Kadota, S; Li, H; Miyahara, T; Seto, H; Tezuka, Y; Tran, QL | 1 |
| NIJLAND, MM; UFFELIE, OF | 1 |
| HNILICA, L; KLIMEK, M | 1 |
| HANNA, C; SCHEIN, FT | 1 |
| MIRZA, R; ROBINSON, R | 1 |
| Holzgrabe, U; Laug, S; Unger, M | 1 |
| Joseph, M; Weber, HA | 1 |
| Bilski, P; Chignell, CF; He, YY; Inbaraj, JJ; Kukielczak, BM; Sik, RH | 1 |
| Abidi, P; Chen, W; Kraemer, FB; Li, H; Liu, J | 1 |
| KEENAN, GL | 1 |
| Douglas, JA; Follett, JM; Littler, RA; Parmenter, GA; Perry, NB; Sansom, CE | 1 |
| Burns, JT; Cech, NB; Ettefagh, KA; Junio, HA; Kaatz, GW | 1 |
| Dunnick, JK; Kissling, GE; Nyska, A; Peckham, J; Sanders, JM; Singh, B | 1 |
| Cech, NB; Cecil, CE; Davis, JM; Laster, SM | 1 |
| Brettell, T; Dawes, ML | 1 |
| Ackermann, LW; Cech, NB; Horswill, AR; Junio, HA; Kavanaugh, JS | 1 |
| Chen, S; Couch, L; Dobrovolsky, VN; Guo, L; Li, Y; Lin, H; Mei, N; Wan, L | 1 |
| Gurley, BJ; Markowitz, JS; Munoz, J; Wang, X; Zhu, HJ | 1 |
| Deng, AJ; Li, J; Li, ZH; Qin, HL; Song, HR; Wang, WJ; Wu, LQ; Zhang, HJ; Zhang, ZH | 1 |
| Backes, JM; Funk, RS; Kandel, SE; Moriarty, PM; Ruisinger, JF; Singh, RK; Winefield, RD | 1 |
| Britton, ER; Cech, NB; Kellogg, JJ; Kvalheim, OM | 1 |
| Cui, R; Fan, J; Gao, S; Jin, Y; Li, B; Zhang, K; Zhu, J | 1 |
| Farjon, J; Giraudeau, P; Le, PM; Martineau, E; Milande, C | 1 |
| Caesar, LK; Cech, NB; Kellogg, JJ; Khin, M | 1 |
| Das, N; Devkota, HP; Ishfaq, PM; Maji, AK; Mandal, SK; Mishra, SK; Silva, AS | 1 |
| Fatima, E; Negi, AS; Pathak, N; Singh, S | 1 |
| Adiwidjaja, J; Boddy, AV; McLachlan, AJ | 1 |
| Arian, CM; Calamia, JC; Nguyen, JT; Paine, MF; Rettie, AE; Tanna, RS; Thummel, KE; Tian, DD | 1 |
25 review(s) available for berberine and curcumin
| Article | Year |
|---|---|
Lipid lowering agents of natural origin: An account of some promising chemotypes.
Topics: Animals; Biological Products; Dyslipidemias; Humans; Hypolipidemic Agents | 2017 |
Plant-derived mPGES-1 inhibitors or suppressors: A new emerging trend in the search for small molecules to combat inflammation.
Topics: Animals; Anti-Inflammatory Agents; Biological Products; Drug Discovery; Enzyme Inhibitors; Humans; Inflammation; Plants, Medicinal; Prostaglandin-E Synthases | 2018 |
Traditional Chinese medicines (TCMs) for molecular targeted therapies of tumours.
Topics: Animals; Antineoplastic Agents, Phytogenic; Arsenic Trioxide; Arsenicals; Artemisinins; Artesunate; Berberine; Biological Products; Cantharidin; Complementary Therapies; Curcumin; Drug Delivery Systems; Drug Screening Assays, Antitumor; Drugs, Chinese Herbal; Humans; Medicine, Chinese Traditional; Models, Biological; Neoplasms; Oxides | 2010 |
Targeting metabolic syndrome: candidate natural agents.
Topics: Animals; Anthocyanins; Berberine; China; Curcumin; Female; Flavanones; Genistein; Ginsenosides; Humans; Male; Medicine, Traditional; Metabolic Syndrome; Mice; Momordica charantia; Phytotherapy; Plant Preparations; Prevalence; Randomized Controlled Trials as Topic; Rats; Resveratrol; Stilbenes | 2010 |
Mechanisms of action of phytochemicals from medicinal herbs in the treatment of Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Berberine; Coptis; Curcuma; Curcumin; Ginsenosides; Humans; Isoflavones; Panax notoginseng; Phytochemicals; Plants, Medicinal; Pueraria; Silybin; Silybum marianum; Silymarin | 2014 |
Preventive and therapeutic role of traditional Chinese herbal medicine in hepatocellular carcinoma.
Topics: Abietanes; Benzylisoquinolines; Berberine; Carcinoma, Hepatocellular; Curcumin; Drugs, Chinese Herbal; Humans; Liver Neoplasms; Medicine, Chinese Traditional; Resveratrol; Scutellaria baicalensis; Stilbenes | 2015 |
A New Insight of Herbal Promises Against Ocular Disorders: An Occuloinformatics Approach.
Topics: Berberine; Computational Biology; Curcumin; Drug Evaluation, Preclinical; Eye Diseases; Ginkgolides; Herbal Medicine; Humans; Inositol; Models, Molecular; Plants, Medicinal | 2016 |
Role of phytochemicals in the management of metabolic syndrome.
Topics: Acrolein; Berberine; Catechin; Cinnamates; Curcumin; Diet; Dietary Fiber; Dietary Supplements; Fatty Acids, Omega-3; Flavonols; Humans; Metabolic Syndrome; Phytochemicals; Psyllium | 2016 |
Regulation of GSK-3 activity by curcumin, berberine and resveratrol: Potential effects on multiple diseases.
Topics: Berberine; Cardiovascular Diseases; Curcumin; Gene Expression Regulation; Glycogen Synthase Kinase 3; Humans; Inflammation; Mechanistic Target of Rapamycin Complex 1; Neoplasms; Neurodegenerative Diseases; Osteoarthritis; Phosphatidylinositol 3-Kinases; Protective Agents; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Resveratrol; Signal Transduction; Stilbenes | 2017 |
Nutraceutical approaches to metabolic syndrome.
Topics: Berberine; Biological Products; Blood Glucose; Blood Pressure; Curcumin; Dietary Supplements; Female; Humans; Insulin Resistance; Lipoprotein Lipase; Male; Metabolic Syndrome; Plant Proteins, Dietary; Prebiotics; Probiotics; Risk Factors; Vitamin D; Waist Circumference | 2017 |
Traditional Chinese medicinal herbs as potential AChE inhibitors for anti-Alzheimer's disease: A review.
Topics: Acetylcholinesterase; Alzheimer Disease; Berberine; Cholinesterase Inhibitors; Curcumin; Drugs, Chinese Herbal; Flavonoids; Ginsenosides; Humans; Medicine, Chinese Traditional | 2017 |
New Insights into the Mechanisms of Chinese Herbal Products on Diabetes: A Focus on the "Bacteria-Mucosal Immunity-Inflammation-Diabetes" Axis.
Topics: Animals; Berberine; Curcumin; Diabetes Mellitus, Type 2; Drugs, Chinese Herbal; Gastrointestinal Microbiome; Ginsenosides; Glucose; Humans; Immunity, Mucosal; Inflammation; Momordica charantia; Plant Extracts | 2017 |
Cholesterol-Lowering Nutraceuticals Affecting Vascular Function and Cardiovascular Disease Risk.
Topics: Anticholesteremic Agents; Berberine; Biological Products; Cardiovascular Diseases; Cholesterol; Curcumin; Dietary Fiber; Dietary Supplements; Glycine max; Humans; Phytosterols; Polyphenols | 2018 |
Sonodynamic therapy: A potential treatment for atherosclerosis.
Topics: Animals; Anthracenes; Antineoplastic Agents; Apoptosis; Atherosclerosis; Berberine; Cell Death; Chalcone; Curcumin; Emodin; Humans; Inflammation; Macrophages; Matrix Metalloproteinases; Mice; Neoplasms; Perylene; Photochemotherapy; Plaque, Atherosclerotic; Quinones; Reactive Oxygen Species; THP-1 Cells; Ultrasonic Therapy | 2018 |
Nutraceutical Approach to Non-Alcoholic Fatty Liver Disease (NAFLD): The Available Clinical Evidence.
Topics: Antioxidants; Berberine; Curcumin; Dietary Supplements; Fatty Acids, Omega-3; Fatty Acids, Unsaturated; Humans; Meta-Analysis as Topic; Non-alcoholic Fatty Liver Disease; Obesity; Observational Studies as Topic; Plant Extracts; Probiotics; Randomized Controlled Trials as Topic; Resveratrol; Salvia miltiorrhiza; Silymarin; Ubiquinone; Vitamin D; Vitamin E; Xanthophylls | 2018 |
A review of the chemopreventative and chemotherapeutic properties of the phytochemicals berberine, resveratrol and curcumin, and their influence on cell death via the pathways of apoptosis and autophagy.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Berberine; Curcumin; Humans; Neoplasms; Phytochemicals; Resveratrol | 2020 |
Clinical Management and Therapeutic Strategies for the Thyroid-Associated Ophthalmopathy: Current and Future Perspectives.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Antioxidants; Berberine; Curcumin; Graves Ophthalmopathy; Humans; Mydriatics; Proto-Oncogene Mas; Quercetin; Resveratrol; Scopolamine; Withanolides | 2020 |
A Novel Promising Frontier for Human Health: The Beneficial Effects of Nutraceuticals in Cardiovascular Diseases.
Topics: Berberine; Biological Products; Brassica; Cardiovascular Diseases; Curcumin; Dietary Supplements; Health; Quercetin; Resveratrol; Spirulina | 2020 |
Potential Role of Natural Products to Combat Radiotherapy and Their Future Perspectives.
Topics: Berberine; Biological Products; Curcumin; Emodin; Genistein; Humans; Neoplasms; Pentacyclic Triterpenes; Radiation-Protective Agents; Radiation-Sensitizing Agents; Radiotherapy; Resveratrol; Sesquiterpenes; Triterpenes; Ursolic Acid; Vitamin D; Withanolides | 2021 |
Potential Therapeutic Effects of Natural Plant Compounds in Kidney Disease.
Topics: Antioxidants; Berberine; Beta vulgaris; Betalains; Biological Products; Catechin; Curcumin; Disulfides; Flavonoids; Humans; Isothiocyanates; Kidney; Kidney Diseases; Plant Extracts; Pomegranate; Protective Agents; Resveratrol; Sulfinic Acids; Sulfoxides; Xanthophylls | 2021 |
Multifaceted role of polyphenols in the treatment and management of neurodegenerative diseases.
Topics: Berberine; Curcumin; Genistein; Humans; Luteolin; Neurodegenerative Diseases; Nitrogen; Oxygen; Polyphenols; Quercetin; Resveratrol; Synthetic Drugs | 2022 |
Natural Phytochemicals as SIRT Activators-Focus on Potential Biochemical Mechanisms.
Topics: Animals; Antioxidants; Berberine; Curcumin; Kaempferols; Mammals; Phytochemicals; Quercetin; Resveratrol; Sirtuin 1 | 2023 |
Pharmacological effects of berberine on mood disorders.
Topics: Animals; Antidepressive Agents; Berberine; Depressive Disorder, Major; Humans; Hydrastis; Mood Disorders; Neuroprotective Agents; Phytotherapy; Plant Preparations | 2019 |
Goldenseal (Hydrastis canadensis L.) and its active constituents: A critical review of their efficacy and toxicological issues.
Topics: Animals; Berberine; Consumer Product Safety; Dietary Supplements; Food Safety; Herb-Drug Interactions; Humans; Hydrastis; Phytochemicals; Plant Extracts; Risk Assessment; Toxicity Tests | 2020 |
Plant isoquinoline alkaloids: Advances in the chemistry and biology of berberine.
Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Berberine; Humans; Hydrastis; Hypoglycemic Agents; Molecular Structure | 2021 |
54 other study(ies) available for berberine and curcumin
| Article | Year |
|---|---|
Optimized protocols for assessing libraries of poorly soluble sortase A inhibitors for antibacterial activity against medically-relevant bacteria, toxicity and enzyme inhibition.
Topics: Aminoacyltransferases; Anti-Bacterial Agents; Bacterial Proteins; Cell Survival; Cysteine Endopeptidases; Dose-Response Relationship, Drug; Enzyme Inhibitors; Escherichia coli; HEK293 Cells; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Pseudomonas aeruginosa; Solubility; Structure-Activity Relationship | 2021 |
[Study on active constituents of traditional Chinese medicine reversing multidrug resistance of tumor cells in vitro].
Topics: Antineoplastic Agents, Phytogenic; Berberine; Curcumin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drugs, Chinese Herbal; Humans; Indoles; Tumor Cells, Cultured; Vincristine | 2001 |
Effects of baicalein, berberine, curcumin and hesperidin on mucin release from airway goblet cells.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Berberine; Cell Line; Coptis; Cricetinae; Curcuma; Curcumin; Dose-Response Relationship, Drug; Flavanones; Flavonoids; Goblet Cells; Hesperidin; Male; Mucins; Phytotherapy; Plants, Medicinal; Poncirus; Scutellaria baicalensis; Trachea | 2003 |
Curcumin inhibits the formation of capillary-like tubes by rat lymphatic endothelial cells.
Topics: Animals; Berberine; Capillaries; Cell Adhesion; Cell Line, Tumor; Cell Survival; Curcumin; Dose-Response Relationship, Drug; Endothelial Cells; I-kappa B Kinase; Matrix Metalloproteinase 2; Neoplasm Metastasis; Proto-Oncogene Proteins c-akt; Rats | 2007 |
Inhibition of progression of erythroleukemia induced by Friend virus in BALB/c mice by natural products--berberine, curcumin and picroliv.
Topics: Animals; Antineoplastic Agents; Berberine; Biological Products; Cinnamates; Curcumin; Disease Progression; Friend murine leukemia virus; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Glycosides; Leukemia, Erythroblastic, Acute; Leukemia, Experimental; Mice; Mice, Inbred BALB C; Uric Acid; Vanillic Acid | 2008 |
A simplified and high-throughput chromogenic assay for testing tissue factor-dependent procoagulant activity.
Topics: Berberine; Blood Coagulation Factors; Cells, Cultured; Chromogenic Compounds; Curcumin; Drug Evaluation, Preclinical; Endothelial Cells; Enzyme Inhibitors; High-Throughput Screening Assays; Humans; Leukocytes, Mononuclear; Lipopolysaccharides; Lipoproteins; Simvastatin; Thromboplastin; Tumor Necrosis Factor-alpha | 2011 |
Evaluation of Synergetic Anticancer Activity of Berberine and Curcumin on Different Models of A549, Hep-G2, MCF-7, Jurkat, and K562 Cell Lines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Berberine; Cell Survival; Curcumin; Dose-Response Relationship, Drug; Drug Synergism; Hep G2 Cells; Humans; Jurkat Cells; K562 Cells; MCF-7 Cells; Neoplasms, Experimental; Treatment Outcome | 2015 |
Berberine and Curcumin Target Survivin and STAT3 in Gastric Cancer Cells and Synergize Actions of Standard Chemotherapeutic 5-Fluorouracil.
Topics: Berberine; Cell Line, Tumor; Cell Survival; Curcumin; DNA; Drug Resistance, Neoplasm; Drug Synergism; Fluorouracil; Humans; Inhibitor of Apoptosis Proteins; NF-kappa B; Quercetin; Signal Transduction; STAT3 Transcription Factor; Stomach Neoplasms; Survivin | 2015 |
Head-to-Head Comparison of Anti-Inflammatory Performance of Known Natural Products In Vitro.
Topics: Acetophenones; Animals; Anti-Inflammatory Agents; Berberine; Biological Products; Blood Platelets; Caco-2 Cells; Catechin; Cell Line; Curcumin; Humans; Interleukin-6; Interleukin-8; Macrophages; Mice; Neutrophils; Platelet Activation; Pravastatin; Prednisolone; Primary Cell Culture; Reactive Oxygen Species; Stilbenes; Tumor Necrosis Factor-alpha | 2016 |
Synergistic chemopreventive effects of curcumin and berberine on human breast cancer cells through induction of apoptosis and autophagic cell death.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Autophagy; Beclin-1; Berberine; Breast Neoplasms; Cell Growth Processes; Chemoprevention; Curcumin; Drug Synergism; Humans; MAP Kinase Kinase 4; MAP Kinase Signaling System; MCF-7 Cells; Proto-Oncogene Proteins c-bcl-2 | 2016 |
Antidiabetic potential of polyherbal formulation DB14201: Preclinical development, safety and efficacy studies.
Topics: 3T3-L1 Cells; Adipocytes; Animals; Berberine; Blood Glucose; Chromatography, Liquid; Curcumin; Diabetes Mellitus, Experimental; Glucose; Hypoglycemic Agents; Insulin; Insulin-Secreting Cells; Kaempferols; Male; Metals, Heavy; Mice; Mice, Inbred C57BL; Plant Extracts; Rats; Rats, Wistar; Tandem Mass Spectrometry; Tumor Necrosis Factor-alpha; Xanthones | 2017 |
Role of nutraceutical SIRT1 modulators in AMPK and mTOR pathway: Evidence of a synergistic effect.
Topics: AMP-Activated Protein Kinases; Anthocyanins; Berberine; Catechin; Cell Line, Tumor; Cell Survival; Coumaric Acids; Curcumin; Dietary Supplements; Gene Expression Regulation; Humans; Niclosamide; Phenylethyl Alcohol; Phosphorylation; Quercetin; Resveratrol; Sirtuin 1; Stilbenes; TOR Serine-Threonine Kinases | 2017 |
Effects of berberine, curcumin, resveratrol alone and in combination with chemotherapeutic drugs and signal transduction inhibitors on cancer cells-Power of nutraceuticals.
Topics: Animals; Antineoplastic Agents; Berberine; Cardiovascular Diseases; Curcumin; Dietary Supplements; Humans; Neoplasms; Resveratrol; Signal Transduction | 2018 |
Natural products berberine and curcumin exhibited better ameliorative effects on rats with non-alcohol fatty liver disease than lovastatin.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Berberine; Biological Products; Blood Glucose; Body Weight; Curcumin; Gene Expression Regulation; Inflammation; Insulin; Intra-Abdominal Fat; Lipid Metabolism; Lipids; Lipopolysaccharides; Liver; Lovastatin; Male; Non-alcoholic Fatty Liver Disease; Organ Size; Oxidative Stress; Rats, Sprague-Dawley | 2018 |
An in vitro comparative study of the antioxidant activity and SIRT1 modulation of natural compounds.
Topics: AMP-Activated Protein Kinase Kinases; Antioxidants; Berberine; Biological Factors; Cell Survival; Curcumin; HeLa Cells; Humans; Oxidative Stress; Protein Kinases; Quercetin; Sirtuin 1 | 2018 |
Novel mitochondrial targeting charge-reversal polysaccharide hybrid shell/core nanoparticles for prolonged systemic circulation and antitumor drug delivery.
Topics: Adenine; Animals; Antineoplastic Agents; Berberine; Cell Line; Chitosan; Curcumin; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Drug Liberation; Endocytosis; Humans; Hyaluronan Receptors; Hyaluronic Acid; Mice; Mice, Nude; Micelles; Mitochondria; Nanoparticles; Polymers; Polysaccharides | 2019 |
Combination treatment of berberine and solid lipid curcumin particles increased cell death and inhibited PI3K/Akt/mTOR pathway of human cultured glioblastoma cells more effectively than did individual treatments.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Berberine; Biological Availability; Brain Neoplasms; Cell Line, Tumor; Cell Proliferation; Cell Survival; Curcumin; Drug Carriers; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Drug Synergism; Glioblastoma; Humans; Lipids; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction; TOR Serine-Threonine Kinases | 2019 |
Synergic Effects of Berberine and Curcumin on Improving Cognitive Function in an Alzheimer's Disease Mouse Model.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid Precursor Protein Secretases; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspartic Acid Endopeptidases; Berberine; Brain; Cognition; Curcumin; Drug Synergism; Female; Male; Mice; Mice, Transgenic; Oxidative Stress; Peptide Fragments | 2020 |
Combinatorial liposomes of berberine and curcumin inhibit biofilm formation and intracellular methicillin resistant
Topics: Animals; Anti-Bacterial Agents; Berberine; Biofilms; Cells, Cultured; Curcumin; Humans; Inflammation; Liposomes; Methicillin-Resistant Staphylococcus aureus; Mice; Microbial Sensitivity Tests; Particle Size; Staphylococcal Infections; Surface Properties; THP-1 Cells | 2021 |
One-step synthesis of red emission multifunctional carbon dots for label-free detection of berberine and curcumin and cell imaging.
Topics: Berberine; Carbon; Curcumin; Fluorescent Dyes; Quantum Dots; Spectrometry, Fluorescence | 2021 |
Is nutraceutical supplementation appropriate for COVID-19 management?
Topics: Berberine; Catechin; COVID-19; Curcumin; Dietary Supplements; Humans; Lactobacillus; NF-E2-Related Factor 2; Receptor, Angiotensin, Type 1; SARS-CoV-2 | 2021 |
Improving the ameliorative effects of berberine and curcumin combination via dextran-coated bilosomes on non-alcohol fatty liver disease in mice.
Topics: Administration, Oral; Animals; Berberine; Biological Availability; Caco-2 Cells; Curcumin; Dextrans; Drug Carriers; Drug Combinations; Humans; Liposomes; Liver; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Tissue Distribution | 2021 |
Evaluation of the Effects of Nanomicellar Curcumin, Berberine, and Their Combination with 5-Fluorouracil on Breast Cancer Cells.
Topics: Apoptosis; Berberine; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Curcumin; Drug Synergism; Female; Fluorouracil; Humans | 2021 |
Fabrication, characterization and in vitro cell exposure study of zein-chitosan nanoparticles for co-delivery of curcumin and berberine.
Topics: Berberine; Chitosan; Curcumin; Nanoparticles; Particle Size; Zein | 2022 |
Carrier-Free Small Molecular Self-Assembly Based on Berberine and Curcumin Incorporated in Submicron Particles for Improving Antimicrobial Activity.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Berberine; Curcumin; Drug Compounding | 2022 |
Standardization and Ameliorative effect of Kalyanaka ghrita in β-amyloid induced memory impairment in wistar rats.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Berberine; Brain-Derived Neurotrophic Factor; Curcumin; Cytokines; Disease Models, Animal; Male; Maze Learning; Memory Disorders; Neuroprotective Agents; Nootropic Agents; Rats; Rats, Wistar; Tannins | 2023 |
A Composition of Phytonutrients for Glycemic and Weight Management.
Topics: Acrolein; Animals; Berberine; Blood Glucose; Curcumin; Diabetes Mellitus; Disease Models, Animal; Fatty Acids; Glycated Hemoglobin; Humans; Insulin; Insulin Resistance; Lipids; Mice; Obesity; Phytochemicals; Weight Gain | 2022 |
Functional Complementation of Anti-Adipogenic Phytonutrients for Obesity Prevention and Management.
Topics: Adipocytes; Adipogenesis; Animals; Berberine; beta Catenin; Cholesterol; Curcumin; Cytokines; Fatty Acids; Glucose; Hesperidin; Humans; Lipoproteins, LDL; Luteolin; Mice; Obesity; Phytochemicals; PPAR gamma; Quercetin; Resveratrol; Sterol Regulatory Element Binding Protein 1; Triglycerides | 2022 |
Virtual screening and antimicrobial evaluation for identification of natural compounds as the prospective inhibitors of antibacterial drug resistance targets in Staphylococcus aureus.
Topics: Anti-Bacterial Agents; Berberine; Curcumin; Drug Resistance, Bacterial; Eugenol; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Quercetin; Staphylococcus aureus; Thymol | 2023 |
Effect of berberine on bone mineral density in SAMP6 as a senile osteoporosis model.
Topics: Aging; Animals; Berberine; Bone Density; Disease Models, Animal; Female; Hydrastis; Male; Mice; Mice, Mutant Strains; Osteoporosis; Ranunculaceae | 2003 |
[Paper chromatographic separation of d- and 1-canadine].
Topics: Berberine; Biological Products; Chromatography, Paper; Hydrastis; Rare Diseases | 1958 |
The influence of deoxyribonucleic acid on ultraviolet and visible light absorption of berberine.
Topics: Berberine; Biological Products; DNA; Hydrastis; Light | 1959 |
The absorption, distribution and excretion of berberine.
Topics: Berberine; Biological Products; Biological Transport; Hydrastis | 1960 |
Conversion of hydrastine into berberine, and an instance of the asymmetrical quaternization of a tertiary base.
Topics: Benzylisoquinolines; Berberine; Biological Products; Humans; Hydrastis | 1950 |
Capillary zone electrophoresis as a tool for the quality control of goldenseal extracts.
Topics: Alkaloids; Benzylisoquinolines; Berberine; Dietary Supplements; Electrophoresis, Capillary; Hydrastis; Plant Extracts; Quality Control; Reproducibility of Results; Sensitivity and Specificity | 2005 |
[Extraction and HPLC analysis of alkaloids in goldenseal].
Topics: Benzylisoquinolines; Berberine; Chromatography, High Pressure Liquid; Hydrastis; Plant Roots | 2004 |
Photochemistry and photocytotoxicity of alkaloids from Goldenseal (Hydrastis canadensis L.). 2. Palmatine, hydrastine, canadine, and hydrastinine.
Topics: Alkaloids; Benzylisoquinolines; Berberine; Berberine Alkaloids; Cell Line; Cell Survival; Humans; Hydrastis; Molecular Structure; Oxygen; Photochemistry; Photosensitizing Agents; Spectrum Analysis; Tetrahydroisoquinolines | 2006 |
The medicinal plant goldenseal is a natural LDL-lowering agent with multiple bioactive components and new action mechanisms.
Topics: Animals; Berberine; Cell Line; Cholesterol, LDL; Cricetinae; Herbal Medicine; Humans; Hydrastis; Liver; Male; Molecular Structure; Phytotherapy; Plant Extracts; Plant Roots; Plants, Medicinal; RNA, Small Interfering | 2006 |
Microscopic identity tests for hydrastis and its principal alkaloids, hydrastine and berberine.
Topics: Alkaloids; Benzylisoquinolines; Berberine; Biological Products; Hydrastis | 1948 |
Seasonal variation of biomass and bioactive alkaloid content of goldenseal, Hydrastis canadensis.
Topics: Benzylisoquinolines; Berberine; Hydrastis; Plant Structures; Seasons | 2010 |
Goldenseal (Hydrastis canadensis L.) extracts synergistically enhance the antibacterial activity of berberine via efflux pump inhibition.
Topics: Alkaloids; Anti-Bacterial Agents; Bacterial Proteins; Benzylisoquinolines; Berberine; Drug Synergism; Ethidium; Hydrastis; Multidrug Resistance-Associated Proteins; Plant Components, Aerial; Plant Extracts; Plant Roots; Staphylococcus aureus | 2011 |
Investigating the potential for toxicity from long-term use of the herbal products, goldenseal and milk thistle.
Topics: Animals; Berberine; Body Weight; Carcinogens; Female; Flavonolignans; Hydrastis; Liver Neoplasms; Male; Mice; Mice, Inbred Strains; Plant Preparations; Plant Roots; Rats; Rats, Inbred F344; Silybin; Silybum marianum; Silymarin; Topoisomerase Inhibitors; Toxicity Tests, Chronic | 2011 |
Inhibition of H1N1 influenza A virus growth and induction of inflammatory mediators by the isoquinoline alkaloid berberine and extracts of goldenseal (Hydrastis canadensis).
Topics: Animals; Antiviral Agents; Berberine; Cell Culture Techniques; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Humans; Hydrastis; Immunoblotting; Immunologic Factors; Influenza A Virus, H1N1 Subtype; Macrophages; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Plant Extracts; Viral Proteins | 2011 |
Analysis of goldenseal, Hydrastis canadensis L., and related alkaloids in urine using HPLC with UV detection.
Topics: Benzylisoquinolines; Berberine; Chromatography, High Pressure Liquid; Humans; Hydrastis; Limit of Detection; Linear Models; Plant Extracts; Plant Roots; Reproducibility of Results; Spectrophotometry, Ultraviolet; Substance Abuse Detection | 2012 |
Quorum quenching and antimicrobial activity of goldenseal (Hydrastis canadensis) against methicillin-resistant Staphylococcus aureus (MRSA).
Topics: Anti-Bacterial Agents; Berberine; Hydrastis; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Molecular Structure; Plant Extracts; Plants, Medicinal; Quorum Sensing; Signal Transduction; Virulence | 2012 |
Mechanism study of goldenseal-associated DNA damage.
Topics: Alkaloids; Berberine; Berberine Alkaloids; Comet Assay; DNA; DNA Damage; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Gene Expression Regulation, Enzymologic; Gene Silencing; Hep G2 Cells; Hepatocytes; Histones; Humans; Hydrastis; Mutagens; Plant Extracts; RNA, Small Interfering; Structure-Activity Relationship | 2013 |
An ex vivo approach to botanical-drug interactions: a proof of concept study.
Topics: Adult; Benzylisoquinolines; Berberine; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP3A; Female; Herb-Drug Interactions; Humans; Hydrastis; Male; Microsomes, Liver; Midazolam; Plant Extracts; Silybin; Silybum marianum; Silymarin; Tolbutamide; Young Adult | 2015 |
Versatile methods for synthesizing organic acid salts of quaternary berberine-type alkaloids as anti-ulcerative colitis agents.
Topics: Berberine; Colitis, Ulcerative; Hydrastis; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Regulatory Factor X Transcription Factors; Salts | 2016 |
Variability in Potency Among Commercial Preparations of Berberine.
Topics: Berberine; Berberis; Capsules; Chromatography, High Pressure Liquid; Costs and Cost Analysis; Dietary Supplements; Food Inspection; Food Labeling; Food Quality; Hydrastis; Hypoglycemic Agents; Hypolipidemic Agents; Internet; Molecular Structure; Pharmacopoeias as Topic; Plant Extracts; Reproducibility of Results; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; United States | 2018 |
Biochemometrics to Identify Synergists and Additives from Botanical Medicines: A Case Study with Hydrastis canadensis (Goldenseal).
Topics: Alkaloids; Anti-Bacterial Agents; Berberine; Biological Products; Flavonoids; Hydrastis; Mass Spectrometry; Metabolomics; Plant Extracts; Staphylococcus aureus | 2018 |
Quantification of natural products in herbal supplements: A combined NMR approach applied on goldenseal.
Topics: Alkaloids; Benzylisoquinolines; Berberine; Biological Products; Chromatography, High Pressure Liquid; Hydrastis; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Mass Spectrometry; Plant Extracts; Plant Roots; Reproducibility of Results | 2019 |
Chemical Evaluation of the Effects of Storage Conditions on the Botanical Goldenseal using Marker-based and Metabolomics Approaches.
Topics: Benzylisoquinolines; Berberine; Berberine Alkaloids; Drug Stability; Drug Storage; Humans; Hydrastis; Infections; Mass Spectrometry; Plant Preparations; Plant Roots; Principal Component Analysis | 2020 |
Physiologically based pharmacokinetic model predictions of natural product-drug interactions between goldenseal, berberine, imatinib and bosutinib.
Topics: Aniline Compounds; Berberine; Biological Products; Cytochrome P-450 CYP3A; Drug Interactions; Humans; Hydrastis; Imatinib Mesylate; Models, Biological; Nitriles; Quinolines | 2022 |
An Integrative Approach to Elucidate Mechanisms Underlying the Pharmacokinetic Goldenseal-Midazolam Interaction: Application of In Vitro Assays and Physiologically Based Pharmacokinetic Models to Understand Clinical Observations.
Topics: Adult; Alkaloids; Berberine; Biological Products; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Humans; Hydrastis; Midazolam; Models, Biological | 2023 |